(Q77137753)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10174323%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Economic evaluation of oral sumatriptan compared with oral caffeine/ergotamine for migraine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10174323%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

K W Evans

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10174323%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J A Boan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10174323%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J L Evans

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10174323%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

A Shuaib

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10174323%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 November 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10174323%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10174323%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10174323%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10174323%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

565-577

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10174323%20AND%20SRC:MED&resulttype=core&format=json

A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group

3 December 2019

cites work

1 reference

12 December 2020

A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group

1 reference

12 December 2020

Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience

1 reference

12 December 2020

Economic evaluation of neonatal intensive care of very-low-birth-weight infants

1 reference

12 December 2020

Treatment of migraine: a new era.

1 reference

12 December 2020

Oral sumatriptan for the long-term treatment of migraine: clinical findings

1 reference

12 December 2020

The safety and tolerability of sumatriptan: an overview

1 reference

12 December 2020

Social evaluation of health care versus personal evaluation of health states. Evidence on the validity of four health-state scaling instruments using Norwegian and Australian surveys

1 reference

12 December 2020

Healthcare resource and lost labour costs of migraine headache in the US.

1 reference

12 December 2020

Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. The Oral Sumatriptan International Multiple-Dose Study Group

1 reference

12 December 2020

The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater

1 reference

12 December 2020

Long-term experience with sumatriptan in the treatment of migraine

1 reference

12 December 2020

Psychoactivity and abuse potential of sumatriptan

1 reference

12 December 2020

Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach

1 reference

12 December 2020

Effect of caffeine on intestinal absorption of ergotamine in man.

1 reference

12 December 2020

Oral sumatriptan compared with placebo in the acute treatment of migraine

1 reference

12 December 2020

Clinical experience with oral sumatriptan: a placebo-controlled, dose-ranging study. Oral Sumatriptan Dose-defining Study Group

1 reference

12 December 2020

Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: results of a multicenter study

1 reference

12 December 2020

The economic cost of migraine. Present state of knowledge

1 reference

12 December 2020

Oral sumatriptan in acute migraine

1 reference

12 December 2020

The pharmacology of the novel 5-HT1-like receptor agonist, GR43175.

1 reference

12 December 2020

The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine

1 reference

12 December 2020

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations

1 reference

12 December 2020

Cost effectiveness of clinical diagnosis, venography, and noninvasive testing in patients with symptomatic deep-vein thrombosis

1 reference

12 December 2020

A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache

1 reference

12 December 2020

Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey

1 reference

12 December 2020

High efficacy and low frequency of headache recurrence after oral sumatriptan. The Oral Sumatriptan Italian Study Group.

1 reference

12 December 2020

A general health policy model: update and applications

1 reference

12 December 2020

Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths

1 reference

12 December 2020

Sumatriptan--an oral dose-defining study. The Oral Sumatriptan Dose-Defining Study Group

1 reference

12 December 2020

Oregon's methods. Did cost-effectiveness analysis fail?

1 reference

12 December 2020

Drug therapy of migraine

1 reference

12 December 2020